Research & Literature

Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays.

D'Souza M, Sarkisian L, Saaby L, et al.

The American journal of medicine 2015; (128(8)):852-60.

Systematic Review and Individual Patient Data Meta-Analysis of Sex Differences in Depression and Prognosis in Persons With Myocardial Infarction: A MINDMAPS Study.

Doyle F, McGee H, Conroy R, et al.

Psychosomatic medicine 2015; (77(4)):419-28 doi:10.1097/PSY.0000000000000174.

Nationwide Analysis of Patients With ST-Segment-Elevation Myocardial Infarction Transferred for Primary Percutaneous Intervention: Findings From the American Heart Association Mission: Lifeline Program.

Dauerman HL, Bates ER, Kontos MC, et al.

Circulation. Cardiovascular interventions 2015; (8(5)).

Psychosocial interventions for smoking cessation in patients with coronary heart disease.

Barth J, Jacob T, Daha I, Critchley JA

The Cochrane database of systematic reviews 2015; CD006886 doi:10.1002/14651858.CD006886.pub2.

[Coronary Artery Bypass Surgery in Acute Coronary Syndrome].

Takase S, Yokoyama H

Kyobu geka. The Japanese journal of thoracic surgery 2015; (68(8)):603-9.

Decision-making microRNAs (miR-124, -133a/b, -34a and -134) in patients with occluded target vessel in acute coronary syndrome.

Gacoń J, Kabłak-Ziembicka A, Stępień E, et al.

Kardiologia polska 2016; (74(3)):280-8 doi:10.5603/KP.a2015.0174.

Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction.

Doll JA, Hellkamp A, Thomas L, et al.

American heart journal 2015; (170(5)):855-64.

Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction.

Schofer N, Brunner FJ, Schlüter M, et al.

European heart journal. Acute cardiovascular care 2017; (6(1)):60-68 doi:10.1177/2048872615626660.

Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1).

Saleh A, Hammoudeh A, Tabbalat R, et al.

Annals of Saudi medicine 2016; (36(1)):17-22 doi:10.5144/0256-4947.2016.17.

ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis.

Stolfo D, Cinquetti M, Merlo M, et al.

International journal of cardiology 2016; (215()):340-5.

Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).

Pandey A, McGuire DK, de Lemos JA, et al.

Circulation. Cardiovascular quality and outcomes 2016; (9(3)):197-205 doi:10.1161/CIRCOUTCOMES.115.002084.

Pathology of coronary atherosclerosis and thrombosis.

Otsuka F, Yasuda S, Noguchi T, Ishibashi-Ueda H

Cardiovascular diagnosis and therapy 2016; (6(4)):396-408 doi:10.21037/cdt.2016.06.01.

Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.

Sim DS, Jeong MH, Ahn Y, et al.

Circulation. Cardiovascular interventions 2016; (9(9)).

[The heart team in planning and performance of revascularization : ESC guidelines versus clinical routine].

Sinning JM, Welz A, Nickenig G

Herz 2016; (41(7)):562-565 doi:10.1007/s00059-016-4477-6.

Antithrombotic therapy for patients with STEMI undergoing primary PCI.

Franchi F, Rollini F, Angiolillo DJ

Nature reviews. Cardiology 2017; (14(6)):361-379 doi:10.1038/nrcardio.2017.18.

Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.

Lettino M, Leonardi S, De Maria E, Halvorsen S

European journal of preventive cardiology 2017; (24(3_suppl)):61-70 doi:10.1177/2047487317707854.

Disparity in ST-segment Elevation Myocardial Infarction Practices and Outcomes in Arabian Gulf Countries (Gulf COAST Registry).

Zubaid M, Rashed W, Alsheikh-Ali AA, et al.

Heart views : the official journal of the Gulf Heart Association 2017; (18(2)):41-46 doi:10.4103/HEARTVIEWS.HEARTVIEWS_113_16.

Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.

Khan AR, Golwala H, Tripathi A, et al.

European heart journal 2017; (38(41)):3082-3089 doi:10.1093/eurheartj/ehx418.

Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients.

Abu-Assi E, Raposeiras-Roubin S, Cobas-Paz R, et al.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2018; (13(16)):1914-1922 doi:10.4244/EIJ-D-17-00550.

Advances in Intravascular Imaging: New Insights into the Vulnerable Plaque from Imaging Studies.

Yonetsu T, Jang IK

Korean circulation journal 2018; (48(1)):1-15 doi:10.4070/kcj.2017.0182.

Evaluation of changes in perfusion defect and left ventricular systolic function using Tc-99m Tetrofosmin single photon emission computed tomography over 3 month period in patients of Acute Myocardial Infarction undergoing primary angioplasty.

Kumar AA, Kumar PG, Swami A, Dinker Y

Nuclear medicine review. Central & Eastern Europe 2018; (21(1)):1-7 doi:10.5603/NMR.a2018.0001.

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.

Guimarães PO, Leonardi S, Huang Z, et al.

American heart journal 2018; (196()):28-35 doi:10.1016/j.ahj.2017.10.007.

Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.

Foo CY, Bonsu KO, Nallamothu BK, et al.

Heart (British Cardiac Society) 2018; (104(16)):1362-1369 doi:10.1136/heartjnl-2017-312517.

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.

Head SJ, Milojevic M, Daemen J, et al.

Lancet (London, England) 2018; (391(10124)):939-948 doi:10.1016/S0140-6736(18)30423-9.

Etiology of Acute Coronary Syndrome after Noncardiac Surgery.

Helwani MA, Amin A, Lavigne P, et al.

Anesthesiology 2018; (128(6)):1084-1091 doi:10.1097/ALN.0000000000002107.

Impact of Type 2 Myocardial Infarction (MI) on Hospital-Level MI Outcomes: Implications for Quality and Public Reporting.

Arora S, Strassle PD, Qamar A, et al.

Journal of the American Heart Association 2018; (7(7)) doi:10.1161/JAHA.118.008661.

Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study.

Berwanger O, Abdelhamid M, Alexander T, et al.

Clinical cardiology 2018; (41(10)):1322-1327 doi:10.1002/clc.23043.

Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock.

Kochar A, Al-Khalidi HR, Hansen SM, et al.

JACC. Cardiovascular interventions 2018; (11(18)):1824-1833 doi:10.1016/j.jcin.2018.06.030.

Update on pathological platelet activation in coronary thrombosis.

Elia E, Montecucco F, Portincasa P, et al.

Journal of cellular physiology 2019; (234(3)):2121-2133 doi:10.1002/jcp.27575.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, et al.

The New England journal of medicine 2018; (379(22)):2097-2107 doi:10.1056/NEJMoa1801174.

The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.

Lambrakis K, French JK, Scott IA, et al.

American heart journal 2019; (208()):11-20 doi:10.1016/j.ahj.2018.09.016.

Reassessing the Mechanisms of Acute Coronary Syndromes.

Libby P, Pasterkamp G, Crea F, Jang IK

Circulation research 2019; (124(1)):150-160 doi:10.1161/CIRCRESAHA.118.311098.

Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.

Tamis-Holland JE, Jneid H, Reynolds HR, et al.

Circulation 2019; (139(18)):e891-e908 doi:10.1161/CIR.0000000000000670.

Patients with ST segment elevation myocardial infarction: moderating effect of perceived control on the relationship between depression and in-hospital complications.

AbuRuz ME

BMC cardiovascular disorders 2019; (19(1)):143 doi:10.1186/s12872-019-1126-z.

Current state-of-play in spontaneous coronary artery dissection.

Franke KB, Wong DTL, Baumann A, et al.

Cardiovascular diagnosis and therapy 2019; (9(3)):281-298 doi:10.21037/cdt.2019.04.03.

Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction.

Twerenbold R, Costabel JP, Nestelberger T, et al.

Journal of the American College of Cardiology 2019; (74(4)):483-494 doi:10.1016/j.jacc.2019.05.046.

Cardiac rehabilitation after acute myocardial infarction in Sweden - evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study.

Ögmundsdottir Michelsen H, Sjölin I, Schlyter M, et al.

European journal of preventive cardiology 2020; (27(1)):18-27 doi:10.1177/2047487319865729.

Does stress echocardiography add incremental value to baseline ejection fraction for the early identification of candidates for implantable defibrillators?

Muhrbeck J, Gunyeli E, Andersson E, et al.

Open heart 2019; (6(2)):e001053 doi:10.1136/openhrt-2019-001053.

Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.

Danchin N, Popovic B, Puymirat E, et al.

European heart journal 2020; (41(7)):858-866 doi:10.1093/eurheartj/ehz665.

Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.

Qintar M, Humphries KH, Park JE, et al.

Journal of the American College of Cardiology 2019; (74(16)):2074-2084 doi:10.1016/j.jacc.2019.07.083.

Cardiac physiology in post myocardial infarction patients: the effect of cardiac rehabilitation programs-a systematic review and update meta-analysis.

Kirolos I, Yakoub D, Pendola F, et al.

Annals of translational medicine 2019; (7(17)):416 doi:10.21037/atm.2019.08.64.

[Severe bleeding with antiplatelet therapy: What to do?]

Cayla G, Cornillet L, Ledermann B, et al.

Presse medicale (Paris, France : 1983) 2019; (48(12)):1416-1421 doi:10.1016/j.lpm.2019.08.017.

Contemporary NSTEMI management: the role of the hospitalist.

Pollack CV, Amin A, Wang T, et al.

Hospital practice (1995) 2020; (48(1)):1-11 doi:10.1080/21548331.2020.1701329.

Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.

Choi KH, Song YB, Lee JM, et al.

Circulation. Cardiovascular interventions 2020; (13(5)):e008530 doi:10.1161/CIRCINTERVENTIONS.119.008530.

Dual Antiplatelet Therapy in Coronary Artery Disease.

Sharma R, Kumar P, Prashanth SP, Belagali Y

Cardiology and therapy 2020; (9(2)):349-361 doi:10.1007/s40119-020-00197-0.

Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden.

Landmesser U, Lindgren P, Hagström E, et al.

European heart journal. Quality of care & clinical outcomes 2022; (8(1)):31-38 doi:10.1093/ehjqcco/qcaa072.

Comparison of the ST-Elevation Myocardial Infarction (STEMI) vs. NSTEMI and Occlusion MI (OMI) vs. NOMI Paradigms of Acute MI.

Meyers HP, Bracey A, Lee D, et al.

The Journal of emergency medicine 2021; (60(3)):273-284 doi:10.1016/j.jemermed.2020.10.026.

Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction.

Redfors B, Mohebi R, Giustino G, et al.

Circulation. Cardiovascular interventions 2021; (14(2)):e009879 doi:10.1161/CIRCINTERVENTIONS.120.009879.

Comparison of cardiac rehabilitation (exercise + education), exercise only, and usual care for patients with coronary artery disease: A non-randomized retrospective analysis.

Hu Y, Li L, Wang T, et al.

Pharmacology research & perspectives 2021; (9(1)):e00711 doi:10.1002/prp2.711.

MINOCA: a heterogenous group of conditions associated with myocardial damage.

Singh T, Chapman AR, Dweck MR, et al.

Heart (British Cardiac Society) 2021; (107(18)):1458-1464 doi:10.1136/heartjnl-2020-318269.

Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction.

Pendell Meyers H, Bracey A, Lee D, et al.

International journal of cardiology. Heart & vasculature 2021; (33()):100767 doi:10.1016/j.ijcha.2021.100767.

Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.

Wereski R, Kimenai DM, Taggart C, et al.

Circulation 2021; (144(7)):528-538 doi:10.1161/CIRCULATIONAHA.121.054302.

Telemedicine Improves the Short-Term Medical Care of Acute ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention.

Kamel H, Hafez MS, Bastawy I

Frontiers in cardiovascular medicine 2021; (8()):693731 doi:10.3389/fcvm.2021.693731.

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

Valgimigli M, Frigoli E, Heg D, et al.

The New England journal of medicine 2021; (385(18)):1643-1655 doi:10.1056/NEJMoa2108749.

Intracranial Hemorrhage During Dual Antiplatelet Therapy: JACC Review Topic of the Week.

Ha ACT, Bhatt DL, Rutka JT, et al.

Journal of the American College of Cardiology 2021; (78(13)):1372-1384 doi:10.1016/j.jacc.2021.07.048.

The presentation of spontaneous coronary artery dissection in the emergency department: Signs and symptoms in an unsuspecting population.

Johnson AK, Tweet MS, Rouleau SG, et al.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2022; (29(4)):423-428 doi:10.1111/acem.14426.

Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes.

Sidhu MS, Lyubarova R, Bangalore S, Bonaca MP

American heart journal 2022; (246()):44-64 doi:10.1016/j.ahj.2021.12.005.

Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment methods.

Leosdottir M, Wärjerstam S, Michelsen HÖ, et al.

Scientific reports 2022; (12(1)):642 doi:10.1038/s41598-021-04634-5.

[Management of acute coronary syndrome without ST-segment elevation].

Rubini Gimenez M, Thiele H, Pöss J

Herz 2022; (47(4)):381-392 doi:10.1007/s00059-022-05120-y.

High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain.

Sandoval Y, Apple FS, Mahler SA, et al.

Circulation 2022; (146(7)):569-581 doi:10.1161/CIRCULATIONAHA.122.059678.

Resumption of Antiplatelet Therapy after Major Bleeding.

Geisler T, Poli S, Huber K, et al.

Thrombosis and haemostasis 2023; (123(2)):135-149 doi:10.1055/s-0042-1750419.

Evidence-Based Clinical Decision Support to Improve Care for Patients Hospitalized With Acute Myocardial Infarction.

Fry C, Engel J, Granger B, et al.

Computers, informatics, nursing : CIN 2023; (41(5)):323-329 doi:10.1097/CIN.0000000000000959.

MINOCA: One Size Fits All? Probably Not-A Review of Etiology, Investigation, and Treatment.

Herling de Oliveira LL, Correia VM, Nicz PFG, et al.

Journal of clinical medicine 2022; (11(19)) doi:10.3390/jcm11195497.

Effects of Cardiac Rehabilitation and Diet Counselling on Adherence to the Mediterranean Lifestyle in Patients after Myocardial Infarction.

Novaković M, Rajkovič U, Košuta D, et al.

Nutrients 2022; (14(19)) doi:10.3390/nu14194048.

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.

Li Y, Liang Z, Qin L, et al.

Lancet (London, England) 2022; (400(10366)):1847-1857 doi:10.1016/S0140-6736(22)01999-7.

Myocardial infarction with non-obstructive coronary arteries (MINOCA).

Yildiz M, Ashokprabhu N, Shewale A, et al.

Frontiers in cardiovascular medicine 2022; (9()):1032436 doi:10.3389/fcvm.2022.1032436.

Myocardial infarction with nonobstructive coronary arteries: from pathophysiology to therapeutic strategies.

Foà A, Canton L, Bodega F, et al.

Journal of cardiovascular medicine (Hagerstown, Md.) 2023; (24(Suppl 2)):e134-e146 doi:10.2459/JCM.0000000000001439.

Prehospital Activation of the Cardiac Catheterization Laboratory in ST-Segment-Elevation Myocardial Infarction for Primary Percutaneous Coronary Intervention.

Savage ML, Hay K, Vollbon W, et al.

Journal of the American Heart Association 2023; (12(14)):e029346 doi:10.1161/JAHA.122.029346.

Significance of Intra-plaque Hemorrhage for the Development of High-Risk Vulnerable Plaque: Current Understanding from Basic to Clinical Points of View.

Sakamoto A, Suwa K, Kawakami R, et al.

International journal of molecular sciences 2023; (24(17)) doi:10.3390/ijms241713298.

A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis.

Pallangyo P, Bhalia SV, Komba M, et al.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 2023; (75(1)):85 doi:10.1186/s43044-023-00408-8.

Psychological impact of first admission with cardiovascular disease in a tertiary hospital in Oman.

Al-Maskari A, Al-Zaabi G, Al-Mamari HA, et al.

Journal of Taibah University Medical Sciences 2024; (19(1)):28-34 doi:10.1016/j.jtumed.2023.08.008.

2023 TAMIS/TSOC/TACVPR Consensus Statement for Patients with Acute Myocardial Infarction Rehabilitation.

Chen KC, Hsu CN, Wu CH, et al.

Acta Cardiologica Sinica 2023; (39(6)):783-806 doi:10.6515/ACS.202311_39(6).20230921A.

Cardiac Rehabilitation After Hospitalization for Acute Coronary Syndrome.

Thakker R, Khan M, Al-Hemyari B

Current cardiology reports 2023; (25(12)):1699-1703 doi:10.1007/s11886-023-02010-5.

Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality.

Abusharekh M, Kampf J, Dykun I, et al.

European heart journal. Quality of care & clinical outcomes 2024; (10(5)):402-410 doi:10.1093/ehjqcco/qcae003.

Peer-support interventions and related outcomes in patients with myocardial infarction: A systematic review.

Heydari A, Manzari ZS, Mohammadpourhodki R

Heliyon 2024; (10(3)):e25314 doi:10.1016/j.heliyon.2024.e25314.

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.

Yndigegn T, Lindahl B, Mars K, et al.

The New England journal of medicine 2024; (390(15)):1372-1381 doi:10.1056/NEJMoa2401479.

Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis.

Hosseini K, Soleimani H, Maleki S, et al.

BMC cardiovascular disorders 2024; (24(1)):395 doi:10.1186/s12872-024-04057-w.

Association between Inflammation and New-Onset Atrial Fibrillation in Acute Coronary Syndromes.

Băghină RM, Crișan S, Luca S, et al.

Journal of clinical medicine 2024; (13(17)) doi:10.3390/jcm13175088.

Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.

Brown TM, Pack QR, Aberegg E, et al.

Circulation 2024; (150(18)):e328-e347 doi:10.1161/CIR.0000000000001289.

Mind the intention-behavior gap: a qualitative study of post-myocardial infarction patients' beliefs and experiences with long-term supervised and self-monitored physical exercise.

Svenningsen A, Söderström S, Bucher Sandbakk S, et al.

BMC sports science, medicine & rehabilitation 2024; (16(1)):204 doi:10.1186/s13102-024-00987-2.

Prevalence of Non-ST-Segment Elevation Myocardial Infarction in Acute Coronary Syndrome With Unremarkable Electrocardiogram: A Cross-Sectional Study From Lady Reading Hospital, Medical Teaching Institute, Peshawar.

Zeb U, Khan NA, Ullah N, Khan MH

Cureus 2024; (16(9)):e70575 doi:10.7759/cureus.70575.

Risk Factors Favoring Plaque Erosion.

Hamana T, Shah P, Grogan A, et al.

Current atherosclerosis reports 2024; (27(1)):17 doi:10.1007/s11883-024-01262-y.

Postacute Myocardial Infarction Differences in Physical Activity Behavior, Anxiety, and Depression Levels.

Shajrawi AM, Al-Akash HY, Al-Smadi AM, et al.

SAGE open nursing 2024; (10()):23779608241304478 doi:10.1177/23779608241304478.

Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation: Endorsed by the American College of Cardiology.

Brown TM, Pack QR, Beregg EA, et al.

Journal of cardiopulmonary rehabilitation and prevention 2025; (45(2)):E6-E25 doi:10.1097/HCR.0000000000000930.

Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series.

Pivina L, Batenova G, Omarov N, et al.

Open access emergency medicine : OAEM 2025; (17()):15-30 doi:10.2147/OAEM.S470523.

PENELOPE 1-year follow-up: legacy effect of a short protocol-led LDL-C-lowering strategy in patients after myocardial infarction.

van der Brug S, van Trier T, Omar Khader A, et al.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2025; (33(4)):120-129 doi:10.1007/s12471-025-01939-2.

Volume of Aerobic Exercise to Optimize Outcomes in Cardiac Rehabilitation: An Official Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation.

Savage PD, Beckie TM, Kaminsky LA, et al.

Journal of cardiopulmonary rehabilitation and prevention 2025; (45(3)):161-168 doi:10.1097/HCR.0000000000000941.

Efficacy and safety of antidepressant in post-myocardial infarction associated depression: a meta-analysis and systematic review.

Wan H, Li H, Luan S, Zhang C

BMC psychiatry 2025; (25(1)):416 doi:10.1186/s12888-025-06843-y.

The Role of Dietary Education in Cardiac Rehabilitation.

Popiolek-Kalisz J, Mazur M, Perone F

Nutrients 2025; (17(6)) doi:10.3390/nu17061082.

The Dose-Response Relationship of Aerobic Exercise on Cardiorespiratory Fitness in Cardiac Rehabilitation: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Collins BEG, Gordon BA, Wundersitz DWT, et al.

Journal of cardiopulmonary rehabilitation and prevention 2025; (45(6)):E53-E70 doi:10.1097/HCR.0000000000000963.

Factors correlated with non-early achievement of target low-density lipoprotein cholesterol level using PCSK9 inhibitors.

Nishino M, Egami Y, Sugino A, et al.

Heart and vessels 2025; (40(12)):1101-1108 doi:10.1007/s00380-025-02571-1.

1-Month Versus 12-Month Dual Antiplatelet Therapy for Patients with Chronic Total Occlusion After Successful Percutaneous Coronary Intervention.

Zhao S, Zhu B, Chen Y, et al.

Drugs & aging 2025; (42(10)):975-985 doi:10.1007/s40266-025-01235-z.

Pathogenesis of plaque erosion.

Riascos-Bernal DF, Quinones G, Abdelaal SA, et al.

Trends in cardiovascular medicine 2026; (36(2)):105-112 doi:10.1016/j.tcm.2025.09.004.

Dyslipidemia Treatment in Patients with Acute Coronary Syndrome: Is It Time to Move to Combination Therapy?

Brie DM, Mornoș C, Adam O, et al.

Journal of clinical medicine 2025; (14(18)) doi:10.3390/jcm14186445.

Beta-Blocker Use in Post-Myocardial Infarction Patients With Preserved Ejection Fraction: A Review.

Maheta D, Shah VS, Agrawal SP, et al.

Cardiology in review 2025; doi:10.1097/CRD.0000000000001066.

Acute coronary-occlusion myocardial infarctions: performance of the STEMI criteria and evolving alternative approaches.

Tudino R, Richardson E, Gonzalez JM, et al.

Trends in cardiovascular medicine 2026; (36(3)):180-187 doi:10.1016/j.tcm.2025.10.006.

Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.

Kristensen AMD, Rossello X, Atar D, et al.

The New England journal of medicine 2026; (394(6)):540-550 doi:10.1056/NEJMoa2512686.

Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trial.

Tavares CAM, Guimarães PO, Franken M, et al.

European heart journal 2025; doi:10.1093/eurheartj/ehaf1050.

Takotsubo Syndrome Presenting as ST-Elevation Myocardial Infarction With Concomitant Persistent High-Grade AV Block Requiring Cardiac Resynchronisation Therapy Pacemaker.

Solano J, Hussain A, Ahmed A, et al.

Case reports in cardiology 2026; (2026()):1482184 doi:10.1155/cric/1482184.

Depression following stroke and myocardial infarction: effective strategies and evidence gaps. A systematic review.

Poostchi AJ, Collett G, Gupta AK

European journal of preventive cardiology 2026; doi:10.1093/eurjpc/zwag144.

Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.

Gorog DA, Ten Berg JM, Campo G, et al.

European heart journal. Acute cardiovascular care 2026; (15(4)):337-363 doi:10.1093/ehjacc/zuag021.

Hematuria Management in Patients on Antiplatelet Medications After Acute Coronary Syndrome: A Review of the Current Evidence and Recommendations.

Loufopoulos I, Kapriniotis K, Fyntanidou B, et al.

Reviews in cardiovascular medicine 2026; (27(3)):46334 doi:10.31083/RCM46334.

Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial.

Holck EN, Holm NR, Hildick-Smith D, et al.

Lancet (London, England) 2026; (407(10536)):1374-1382 doi:10.1016/S0140-6736(26)00205-9.

Stent thrombosis: an updated clinical overview from epidemiology to classification and management.

Granata LG, Marchetta M, Alagna G, et al.

Heart (British Cardiac Society) 2026; doi:10.1136/heartjnl-2026-327899.

P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis.

Spagnolo M, Imbesi A, Bordonaro CA, et al.

European heart journal 2026; doi:10.1093/eurheartj/ehag381.

Singapore expert consensus on optimising lipid-lowering strategies in acute coronary syndrome: A modified Delphi study.

Tan RS, Yap J, Yeo C, et al.

Annals of the Academy of Medicine, Singapore 2026; (55(6)):318-331 doi:10.47102/annals-acadmedsg.2025459.

Left Ventricular Ejection Fraction Trajectory and Long-Term Outcomes Following Percutaneous Coronary Intervention for Myocardial Infarction.

Sampath-Kumar R, von Koch S, Mohammad MA, et al.

JACC. Advances 2026; (5(7)):102881 doi:10.1016/j.jacadv.2026.102881.

Coronary Calcified Nodules: From Pathological Definitions to Intravascular Imaging- and Morphology-Guided PCI.

Lucki M, Iwańczyk S, Lucka E, et al.

International journal of molecular sciences 2026; (27(15)) doi:10.3390/ijms27156999.